Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine initiation before discharge in heart failure
NCT02827500Phase 4Completed
- Sponsor
- Duke University
- Start
- Jul 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ivabradine in heart failure with reduced ejection fraction (HFrEF), sponsored by Duke University. Started Jul 2016; status: completed.
02
Drugs
ivabradine
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT02827500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02827500.